Phase 2 Occlusion Clinical Trials
13 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–13 of 13 trials
Recruiting
Phase 2Phase 3
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Basilar Artery Occlusion
University of Melbourne688 enrolled17 locationsNCT05105633
Recruiting
Phase 2
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
ThrombectomyIschemia StrokeLarge Vessel Occlusion
Tang-Du Hospital210 enrolled1 locationNCT07516522
Recruiting
Phase 2Phase 3
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion
Acute Ischemic StrokeMedium Vessel Occlusion
Xiang Luo382 enrolled1 locationNCT07302854
Recruiting
Phase 2
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
Acute Ischemic Stroke From Large Vessel Occlusion
University of Pennsylvania20 enrolled1 locationNCT06904911
Recruiting
Phase 2
Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects
Occlusion
Rutgers, The State University of New Jersey20 enrolled1 locationNCT05507164
Recruiting
Phase 2
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB12 enrolled1 locationNCT07259928
Recruiting
Phase 2
Safety, Tolerability and Efficacy of Adjunctive TBO-309 in Reperfusion for Stroke With Tandem Occlusion
Ischemic StrokeTandem Occlusion
ThromBio Pty. Ltd.78 enrolled2 locationsNCT06813651
Recruiting
Phase 2
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd.160 enrolled49 locationsNCT07205887
Recruiting
Phase 2
PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
Coronary DiseaseBleedingCoronary Artery Disease+5 more
Federal University of São Paulo120 enrolled1 locationNCT06542393
Completed
Phase 2
Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.
Central retinal vein occlusion
Salahuddin34 enrolled1 locationACTRN12622000267752
Terminated
Phase 2
Tenecteplase in the acute management of branch retinal vein occlusion.
Branch retinal vein occlusion.
Lions Eye Institute40 enrolled2 locationsACTRN12615000185561
Recruiting
Phase 2
Bevacizumab intravitreal injection in the treatment of patients with Central Retinal Vein Occlusion.
Central retinal vein occlusion (CRVO)
Royal Adelaide Hospital22 enrolled1 locationACTRN12611000300976
Completed
Phase 2
The Efficacy and Safety of Treatment with Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.
Macula oedema secondary to Branch Retinal Vein Occlusion.
Associate Professor Ian McAllister40 enrolled1 locationACTRN12607000262404